Delivery Order SPE2DX22D0010-SPE2D826FCE53
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order contract valued at $1,074.78 by the Defense Logistics Agency Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order, which utilizes no set-aside designation, represents a task order under a larger Indefinite Delivery Contract vehicle. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania....
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $77,859.60 by the Defense Logistics Agency Medical Supply Chain on January 6, 2026. The firm fixed-price contract, which carries no set-aside designation, has an ultimate completion date of January 7, 2026 and will be performed in Conshohocken, Pennsylvania, where the company maintains its corporate office. This delivery order represents a task order under a larger contracting vehicle and...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $31,173.60 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a $74,044.06 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This non-set-aside, competitively awarded contract represents a single delivery order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026. The work will be...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $7,785.54 on January 6, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract is a child order under a larger Indefinite Delivery Contract vehicle with a ceiling value of $999,999,999.00 that runs through December 2026. The delivery order is scheduled for completion by January 7, 2026, with performance occurring at the company's corporate office...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $14,865.12 on January 6, 2026, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price, non-set-aside delivery order is scheduled for completion by January 7, 2026, with performance taking place at the company's Corporate Office location in Conshohocken, Pennsylvania. The award represents a task order issued under a larger contracting vehicle supporting federal...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $8,771.85 on January 6, 2026, by the Defense Logistics Agency's Medical Supply Chain with an ultimate completion date of January 7, 2026. This firm fixed-price, non-set-aside contract represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 through December 2026. The work...
- AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $1,144.41 on January 6, 2026, by the Defense Logistics Agency's Medical Supply Chain, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order represents a child contract under a larger indefinite delivery vehicle and was competitively awarded without set-aside designation. The work will be performed at the awardee's corporate office location in Conshohocken,...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $149,401.15 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract that leverages the company's existing Indefinite Delivery Contract with DLA Troop Support Medical valued at up to...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $15,345.00 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price, non-set-aside contract represents a child delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract will be performed at the...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FCE53Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $1,359.62 on January 6, 2026, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price, non-set-aside contract is expected to reach completion by January 7, 2026, with performance occurring at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a task order under Amerisourcebergen's broader Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. Amerisourcebergen Drug Corp serves as a critical pharmaceutical and medical supply vendor for federal healthcare systems, supplying a comprehensive range of products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military and veteran healthcare programs globally. The company's consistent receipt of competitively awarded, non-set-aside delivery orders demonstrates its established capability to meet federal procurement requirements and its position as a primary vendor within the Defense Logistics Agency's pharmaceutical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 1/5/26 |